Speaker illustration

Doctor Alessandro Spirito

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Member of:

European Society of Cardiology

Studied in Genova, Italy 2011-2015 Residency (Internal Medicine) in Lugano&Lausanne, Switzerland 2015-2019 Fellowship in Cardiology at Bern University Hospital, Switzerland 2019-2021 Attending Physician in General Cardiology at Bern University Hospital, Bern, Switzerland (Prof. Windecker and Prof. Valgimigli Switzerland) since September 2021 Research Fellow at Mount Sinai Hospital, New York, USA (Prof. Mehran)

Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 3

Thumbnail

Safety and Efficacy of Biodegradable Polymer Biolimus-Eluting Stents in Patients with Non-ST-elevation Acute Coronary Syndrome: A Pooled Analysis of GLASSY and TWILIGHT

Event: ESC Congress 2022

Topic: Devices

Session: Acute coronary syndromes in complex patients and lesions: what’s new?

Thumbnail

Impact of body mass index on outcomes in patients undergoing percutaneous coronary intervention for in-stent restenosis

Event: ESC Congress 2022

Topic: Complications

Session: Long-term PCI outcomes

Thumbnail

This platform is supported by

logo Novo Nordisk